M. McDonald

Mutations in a Conserved Residue in the Influenza Virus Neuraminidase Active Site Decreases Sensitivity to Neu5Ac2en-Derived Inhibitors

P. Colman, J. Varghese, R. Bethell, 1998, Journal of Virology.

Reduced susceptibility to all neuraminidase inhibitors of influenza H1N1 viruses with haemagglutinin mutations and mutations in non-conserved residues of the neuraminidase.

M. Tashiro, J. McKimm-Breschkin, P. Mohr, 2013, The Journal of antimicrobial chemotherapy.

Tethered neuraminidase inhibitors that bind an influenza virus: a first step towards a diagnostic method for influenza.

P. Colman, J. McKimm-Breschkin, S. Tucker, 2003, Angewandte Chemie.

The interaction of neuraminidase and hemagglutinin mutations in influenza virus in resistance to 4-guanidino-Neu5Ac2en.

J. McKimm-Breschkin, T. Blick, A. Sahasrabudhe, 1998, Virology.

Mechanisms of resistance of influenza virus to neuraminidase inhibitors

J. McKimm-Breschkin, T. Blick, A. Sahasrabudhe, 2001 .

Identification of a human influenza type B strain with reduced sensitivity to neuraminidase inhibitor drugs.

I. Barr, A. Hurt, J. McKimm-Breschkin, 2004, Virus research.

Mutation in the influenza virus neuraminidase gene resulting in decreased sensitivity to the neuraminidase inhibitor 4-guanidino-Neu5Ac2en leads to instability of the enzyme.

P. Colman, J. McKimm-Breschkin, T. Blick, 1996, Virology.

Structural studies of the resistance of influenza virus neuramindase to inhibitors.

Brian J Smith, Brian J. Smith, P. Colman, 2002, Journal of medicinal chemistry.